(Q43945425)

28 November 2017

title

Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles (English)

1 reference

15 November 2022

1 reference

1 reference

15 November 2022

author name string

L. S. Hermann

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1748145

15 November 2022

J. E. Karlsson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1748145

15 November 2022

A. Sjöstrand

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1748145

15 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1748145

15 November 2022

publication date

1 January 1991

1 reference

full work available at URL

28 November 2017

http://link.springer.com/content/pdf/10.1007/BF00315441.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00315441/fulltext.html

15 November 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF00315441

15 November 2022

1 reference

European Journal of Clinical Pharmacology

15 November 2022

published in

1 reference

28 November 2017

volume

41

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

263-265

1 reference

The effect of glibenclamide and metformin on serum lipoproteins in type 2 diabetes

28 November 2017

cites work

1 reference

12 December 2020

The reduction of low density lipoprotein cholesterol by metformin is maintained with long-term therapy.

1 reference

12 December 2020

A prospective study of the effect of 12 months treatment on serum lipids and apolipoproteins A-I and B in Type 2 (non-insulin-dependent) diabetes

1 reference

12 December 2020

Oral hypoglycemic agents

1 reference

12 December 2020

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients

1 reference

12 December 2020

Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects.

1 reference

12 December 2020

Lipids, diabetes, and vascular disease: the time to act.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00315441

1 reference

28 November 2017

1 reference